Dela Rosa, Maricel .

HRN: 28-62-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
CO-AMOXICLAV 625MG (TAB)
03/03/2026
03/09/2026
ORAL
625 Mg
BID
3rd Degree Perineal Laceration
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: